2 FTSE 100 and FTSE 250 shares I’d buy for £1,310 of passive income in 2024!

UK shares have proved to be a great way for investors to generate a healthy passive income. Here are two I’d buy if I had spare cash to invest.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young mixed-race woman jumping for joy in a park with confetti falling around her

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The London Stock Exchange is packed with brilliant bargains following market volatility in 2023. So I’ve been searching the FTSE 100 and FTSE 250 for stocks that could boost my passive income.

These UK shares offer dividend yields well above the Footsie forward average of 3.8% for next year. If City forecasts prove correct, I’d make a second income of £1,310 if I invested £20,000 evenly across both.

Here’s why I think they could be excellent sources of dividend income for years to come.

Target Healthcare REIT

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice.

News of dividend reductions tends to send a chill down the spine of investors. Earlier this year Target Healthcare REIT (LSE:THRL) shocked the market when it announced plans to rebase its annual dividend to 5.6p per share.

But revisions to a payout policy aren’t always a bad thing. In the case of FTSE 250-quoted Target, it gives the company — which owns and operates 97 care home facilities — a better chance to grow its portfolio.

I think this real estate investment trust (or REIT) is a great way to capitalise on Britain’s soaring elderly population. As life expectancies increase and the number of people needing social care rises, the care home sector is tipped to grow strongly, as the chart below shows.

Chart showing population age forecasts for the UK.
Source: Target Healthcare REIT

I also like the peace of mind that it provides me as an investor. Its tenants are tied down on extra-long-term contracts (its average unexpired lease term stands at 26.5 years). Its properties are also let out to 32 different clients, cutting the risk of rent collection problems.

Under REIT regulations, Target has to pay at least 90% of annual rental income out in the form of dividends. This explains why the company carries a healthy 7.4% dividend yield for this financial year (to June 2024).

Nursing staff shortages could hamper the firm’s performance. But on balance I still expect earnings (and therefore dividends) here to grow strongly.

WPP

The global advertising sector is plagued with uncertainty going into 2024. Agencies like WPP (LSE:WPP) may continue to struggle if tough economic conditions persist and companies cut back on spending.

However, I’m still expecting this FTSE 100 company to pay the huge dividends City analysts are currently expecting. Firstly, predicted payouts for next year are covered 2.4 times over by anticipated earnings. This provides a wide margin of safety.

WPP also has a strong balance sheet it can fall back on to help it meet dividend forecasts if needed. Its net debt to EBITDA sat within target at 1.68 times as of June.

Chart showing predicted digital advertising growth.
Source: Precedence Research

I think this 5.7%-yielding share could be a great way to generate long-term passive income. The company is spending huge sums on digital advertising, a sector that’s tipped to explode over the next decade as the technological revolution rolls on. This is illustrated in the chart above.

I’m also confident in WPP because of its broad geographic footprint. This gives it excellent exposure to fast-growing emerging economies which it’s likely to keep building through further acquisitions.

Royston Wild has positions in Target Healthcare REIT Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

Can Barclays shares do it all over again in 2026?

Barclays shares had a spectacular return in 2025, rising by 76.8%. Muhammad Cheema takes a look to see if they…

Read more »

Investing Articles

This FTSE 100 stock supercharged my SIPP in 2025. Can it repeat the trick in 2026?

A FTSE 100 stock has lifted my SIPP this year, showing how long-term thinking, volatility, and optionality can shape retirement…

Read more »

UK supporters with flag
Investing Articles

£1k invested in the UK stock market during the pandemic is currently worth…

Jon Smith not only points out the specific gains from investing in the stock market generally since the pandemic, but…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Will Nvidia shares continue surging in 2026 and beyond?

2026 will be an exciting year for Nvidia shares as the semiconductor giant launches its latest generation of AI chips.…

Read more »

Investing Articles

Check out the BP share price and dividend forecast for 2026 – it’s hard to believe!

Harvey Jones is feeling rather glum about the BP share price but analysts reckon it's good to go. So who's…

Read more »

Investing Articles

I asked ChatGPT for its top FTSE 100 stock for 2026, and it said…

Muhammad Cheema asked ChatGPT for its top FTSE 100 pick, and its response surprised him. He thinks he’s found an…

Read more »

Investing Articles

By the end of 2026, can Rolls-Royce shares hit £17?

Rolls-Royce shares have had another phenomenal year, rising by 95.4%. Muhammad Cheema takes a look at whether they can continue…

Read more »

Investing Articles

Will Barclays shares continue their epic run into 2026 and beyond?

Noting that difference of opinion is a global norm, Zaven Boyrazian discusses what the experts think will happen to Barclays…

Read more »